DK1424066T3 - Törre sammensætninger omfattende hydrofobe stabilisatorer - Google Patents
Törre sammensætninger omfattende hydrofobe stabilisatorerInfo
- Publication number
- DK1424066T3 DK1424066T3 DK04002580T DK04002580T DK1424066T3 DK 1424066 T3 DK1424066 T3 DK 1424066T3 DK 04002580 T DK04002580 T DK 04002580T DK 04002580 T DK04002580 T DK 04002580T DK 1424066 T3 DK1424066 T3 DK 1424066T3
- Authority
- DK
- Denmark
- Prior art keywords
- dry compositions
- hydrophobic stabilizers
- stabilizers
- hydrophobic
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33671495 | 1995-12-25 | ||
| PCT/JP1996/003772 WO1997023239A1 (en) | 1995-12-25 | 1996-12-25 | Dry compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1424066T3 true DK1424066T3 (da) | 2008-05-26 |
Family
ID=18302038
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04002580T DK1424066T3 (da) | 1995-12-25 | 1996-12-25 | Törre sammensætninger omfattende hydrofobe stabilisatorer |
| DK96942636T DK0869816T3 (da) | 1995-12-25 | 1996-12-25 | Törre sammensætninger omfattende hydrofobe stabilisatorer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96942636T DK0869816T3 (da) | 1995-12-25 | 1996-12-25 | Törre sammensætninger omfattende hydrofobe stabilisatorer |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP1424066B1 (da) |
| JP (2) | JP3208441B2 (da) |
| KR (1) | KR100461291B1 (da) |
| CN (1) | CN101279095A (da) |
| AR (1) | AR005274A1 (da) |
| AT (2) | ATE284713T1 (da) |
| AU (1) | AU705094B2 (da) |
| BR (1) | BR9612236A (da) |
| CA (1) | CA2241179C (da) |
| DE (2) | DE69634046T2 (da) |
| DK (2) | DK1424066T3 (da) |
| ES (2) | ES2233983T3 (da) |
| MX (1) | MX9805196A (da) |
| PT (2) | PT1424066E (da) |
| TW (1) | TW403653B (da) |
| WO (1) | WO1997023239A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| ID24279A (id) * | 1998-06-26 | 2000-07-13 | Otsuka Pharma Co Ltd | Komposisi kering yang terlarut dalam air |
| MXPA02004193A (es) * | 1999-10-29 | 2002-12-13 | Inhale Therapeutic Syst | Composiciones de polvo seco que tienen caracteristicas de dispersion mejoradas. |
| PT1254944E (pt) * | 1999-12-24 | 2007-06-08 | Otsuka Pharma Co Ltd | Composições anidras contendo aminoácidos hidrofóbicos. |
| AU2002224526A1 (en) | 2000-07-24 | 2002-02-05 | Ono Pharmaceutical Co. Ltd. | Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the same |
| CA2433037C (en) * | 2000-12-28 | 2010-12-21 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| EG24184A (en) * | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| KR100815216B1 (ko) * | 2001-06-15 | 2008-03-19 | 오츠카 세이야쿠 가부시키가이샤 | 경폐 투여용 건조 분말 흡입 시스템 |
| AU2003207244A1 (en) * | 2002-02-22 | 2003-09-09 | Ajinomoto Co., Inc. | Amino acid powder and process for producing the same |
| JP5057648B2 (ja) * | 2002-09-26 | 2012-10-24 | 塩野義製薬株式会社 | 安定化されたタンパク組成物 |
| WO2004028472A2 (en) * | 2002-09-27 | 2004-04-08 | Biogen Idec Ma Inc. | THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
| DE102004022927A1 (de) * | 2004-05-10 | 2005-12-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten |
| WO2006062238A1 (ja) * | 2004-12-07 | 2006-06-15 | Ajinomoto Co., Inc. | アミノ酸の微粉末及びその懸濁液 |
| TW200640492A (en) * | 2005-02-21 | 2006-12-01 | Lg Life Sciences Ltd | Sustained release composition of protein drug |
| JP5034944B2 (ja) * | 2005-07-27 | 2012-09-26 | 味の素株式会社 | インターフェロン作用物質の活性増強剤 |
| US20100184059A1 (en) * | 2007-06-16 | 2010-07-22 | Enigma Diagnostics Limited | Compositions |
| BR112016000937A8 (pt) * | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
| CN104472877B (zh) * | 2014-12-17 | 2017-07-18 | 宁夏伊品生物科技股份有限公司 | L‑赖氨酸制品的制备工艺 |
| US20200146989A1 (en) * | 2016-12-23 | 2020-05-14 | University Of Copenhagen | A co-amorphous form of a substance and a dipeptide |
| JP7149630B2 (ja) | 2021-01-14 | 2022-10-07 | 株式会社G.A.Yellows | 樹脂リム一体型金属眼鏡フレーム |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0341033A (ja) * | 1989-07-07 | 1991-02-21 | Kyowa Hakko Kogyo Co Ltd | 安定なモチリン類含有製剤 |
| EP0578823B1 (en) * | 1991-04-08 | 2002-01-23 | Sumitomo Pharmaceuticals Company, Limited | Porous solid preparation containing physiologically active protein substance |
| US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| NZ285664A (en) * | 1994-05-18 | 1998-07-28 | Inhale Therapeutic Syst | Dry powder interferon composition adapted for pulmonary delivery |
| US6117455A (en) * | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
-
1996
- 1996-12-24 TW TW085116021A patent/TW403653B/zh not_active IP Right Cessation
- 1996-12-25 EP EP04002580A patent/EP1424066B1/en not_active Expired - Lifetime
- 1996-12-25 PT PT04002580T patent/PT1424066E/pt unknown
- 1996-12-25 EP EP96942636A patent/EP0869816B1/en not_active Expired - Lifetime
- 1996-12-25 AT AT96942636T patent/ATE284713T1/de active
- 1996-12-25 PT PT96942636T patent/PT869816E/pt unknown
- 1996-12-25 DK DK04002580T patent/DK1424066T3/da active
- 1996-12-25 ES ES96942636T patent/ES2233983T3/es not_active Expired - Lifetime
- 1996-12-25 DE DE69634046T patent/DE69634046T2/de not_active Expired - Lifetime
- 1996-12-25 WO PCT/JP1996/003772 patent/WO1997023239A1/en active IP Right Grant
- 1996-12-25 DE DE69637450T patent/DE69637450T2/de not_active Expired - Lifetime
- 1996-12-25 AU AU11732/97A patent/AU705094B2/en not_active Ceased
- 1996-12-25 BR BR9612236A patent/BR9612236A/pt not_active IP Right Cessation
- 1996-12-25 DK DK96942636T patent/DK0869816T3/da active
- 1996-12-25 ES ES04002580T patent/ES2300667T3/es not_active Expired - Lifetime
- 1996-12-25 KR KR10-1998-0704875A patent/KR100461291B1/ko not_active IP Right Cessation
- 1996-12-25 AT AT04002580T patent/ATE387188T1/de active
- 1996-12-25 JP JP34505496A patent/JP3208441B2/ja not_active Expired - Fee Related
- 1996-12-25 CA CA2241179A patent/CA2241179C/en not_active Expired - Fee Related
- 1996-12-25 CN CNA2008100870983A patent/CN101279095A/zh active Pending
- 1996-12-26 AR ARP960105889A patent/AR005274A1/es active IP Right Grant
-
1998
- 1998-06-25 MX MX9805196A patent/MX9805196A/es not_active IP Right Cessation
-
2000
- 2000-12-27 JP JP2000398486A patent/JP4099623B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09235238A (ja) | 1997-09-09 |
| PT1424066E (pt) | 2008-04-23 |
| JP4099623B2 (ja) | 2008-06-11 |
| EP0869816B1 (en) | 2004-12-15 |
| JP2001172198A (ja) | 2001-06-26 |
| EP1424066B1 (en) | 2008-02-27 |
| TW403653B (en) | 2000-09-01 |
| EP1424066A1 (en) | 2004-06-02 |
| KR100461291B1 (ko) | 2005-02-28 |
| DK0869816T3 (da) | 2005-01-31 |
| AR005274A1 (es) | 1999-04-28 |
| ES2233983T3 (es) | 2005-06-16 |
| CA2241179A1 (en) | 1997-07-03 |
| DE69634046T2 (de) | 2005-12-22 |
| MX9805196A (es) | 1998-10-31 |
| ATE284713T1 (de) | 2005-01-15 |
| ATE387188T1 (de) | 2008-03-15 |
| CN101279095A (zh) | 2008-10-08 |
| WO1997023239A1 (en) | 1997-07-03 |
| AU1173297A (en) | 1997-07-17 |
| BR9612236A (pt) | 1999-07-13 |
| KR19990076752A (ko) | 1999-10-15 |
| AU705094B2 (en) | 1999-05-13 |
| JP3208441B2 (ja) | 2001-09-10 |
| CA2241179C (en) | 2010-10-19 |
| EP0869816A1 (en) | 1998-10-14 |
| DE69637450D1 (de) | 2008-04-10 |
| PT869816E (pt) | 2005-03-31 |
| DE69637450T2 (de) | 2009-02-19 |
| DE69634046D1 (de) | 2005-01-20 |
| ES2300667T3 (es) | 2008-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI974241A0 (fi) | BPM-15 -koostumukset | |
| DK0869816T3 (da) | Törre sammensætninger omfattende hydrofobe stabilisatorer | |
| DE69630168D1 (de) | Olefin-thermoplastische Elastomerzusammensetzungen | |
| FI970741A0 (fi) | Pinta-aktiiviset valmisteet | |
| FI970742A (fi) | Pinta-aktiiviset valmisteet | |
| DE69704864D1 (de) | Stabilisatorzusammensetzungen | |
| DE69610553D1 (de) | Deodorant zusammensetzungen | |
| NO981568D0 (no) | Randtennings-tennsatssammensetninger | |
| DE69626835D1 (de) | Insektizide zusammensetzung | |
| DE69617029D1 (de) | Organoton-zusammensetzungen | |
| BR9607925A (pt) | Composição fungicida | |
| ATA181095A (de) | Probiotisch wirksame formulierung | |
| DE59606968D1 (de) | Trockenpartie | |
| FI960785A0 (fi) | Kuivatusosa | |
| FI963631A0 (fi) | Insektisidisia tehoainekoostumuksia | |
| DE69603228D1 (de) | Aluminoxanate-Zusammensetzungen | |
| ATE206150T1 (de) | Farbstoffstabilisierte zusammensetzungen | |
| NO981340D0 (no) | Stabiliserte fosfolipidsammensetninger | |
| ATA55694A (de) | Trockenentstauber | |
| DE69615586D1 (de) | Polyelektrolyte enthaltende zusammensetzungen | |
| EE9800168A (et) | Tahked kompositsioonid | |
| NO980010D0 (no) | Pesticidale sammensetninger | |
| DE69623854D1 (de) | Trockenätzverfahren | |
| BR9609180A (pt) | Composições alvejantes | |
| KR970028635U (ko) | 스테이빌라이저 |